Table 4. Enzyme production profiles tested by API ZYM kit and antibiotic resistance of L. brevis SCML 432

Enzymes SCML 432 antibiotic SCML 432
Control -1) Cephalothin (CF/30 μg) ND3)
Alkaline phospatase - Neomycin (N/30 μg) S4)
Esterase (C4) +2) Lincomycin (L/2 μg) ND
Esterase lipase (C8) + Doxycycline (D/30 μg) SS
Lipase (C14) - Tetracycline (TE/30 μg) S
Leucine arylamidase + Gentamicin (GM/10 μg) S
Valine arylamidase + Colistin (CL/10 μg) ND
Cystine arylamidase - Amocicillin/Clavulanic acid (AMC/20, 10 μg) SS
Trypsin - Ciprofloxacin (CIP/5 μg) ND
α-Chymotrypsin - Streptomycin (D/10 μg) ND
Acid phosphatase + Norfloxacin (NOR/10 μg) ND
Naphol-AS-BI-phosphohydrolase + Kanamycin (K/30 μg) ND
α-Galactosidase + Ampicillin (AM/10 μg) SS
β-Galactosidase + Erythromycin (E/15 μg) SS
β-Galucuronidase + Amikacin (AN/30 μg) ND
α-Galcosidase - Rimethoprim/Sulfamethoxazole(SXT/1.25, 23.75 μg) ND
β-Galcosidase +
N-Acetyl-β-galcosaminidase +
α-Mannosidase -
α-Fucosidase -
1)Negative effect.
2)Positive effect.
3)Not detected.
4)SS, 1.6-2.0; S, 1.2-1.5.